Literature DB >> 26187021

Intravenous Artesunate Reduces Parasite Clearance Time, Duration of Intensive Care, and Hospital Treatment in Patients With Severe Malaria in Europe: The TropNet Severe Malaria Study.

Florian Kurth1, Michel Develoux2, Matthieu Mechain3, Jan Clerinx4, Spinello Antinori5, Ida E Gjørup6, Joaquím Gascon7, Kristine Mørch8, Emanuele Nicastri9, Michael Ramharter10, Alessandro Bartoloni11, Leo Visser12, Thierry Rolling13, Philipp Zanger14, Guido Calleri15, Joaquín Salas-Coronas16, Henrik Nielsen17, Gudrun Just-Nübling18, Andreas Neumayr19, Anna Hachfeld20, Matthias L Schmid21, Pietro Antonini22, Peter Pongratz1, Peter Kern23, José Saraiva da Cunha24, Antoni Soriano-Arandes25, Mirjam Schunk26, Norbert Suttorp1, Christoph Hatz19, Thomas Zoller19.   

Abstract

Intravenous artesunate improves survival in severe malaria, but clinical trial data from nonendemic countries are scarce. The TropNet severe malaria database was analyzed to compare outcomes of artesunate vs quinine treatment. Artesunate reduced parasite clearance time and duration of intensive care unit and hospital treatment in European patients with imported severe malaria.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Plasmodium falciparum; artesunate; clinical study; quinine; severe malaria

Mesh：

Substances：

Year:  2015        PMID： 26187021     DOI： 10.1093/cid/civ575

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  10 in total

1.  Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study.

Authors:  Fabrice Bruneel; Florence Tubach; Jean-Paul Mira; Sandrine Houze; Sebastien Gibot; Marie-Genevieve Huisse; Bruno Megarbane; Christophe Choquet; Philippe Corne; Eric Peytel; Daniel Villers; Christophe Camus; Olivier Bouchaud; Eric Caumes; Pierre-Marie Girard; Fabrice Simon; Antoine Kalloumeh; Carine Roy; Remy Durand; Jacques Le Bras; Sophie Matheron; Michel Wolff
Journal:  Intensive Care Med       Date:  2016-05-11       Impact factor: 17.440

2.  Assessment of electronic surveillance and knowledge, attitudes, and practice (KAP) survey toward imported malaria surveillance system acceptance in France.

Authors:  Marc Thellier; Sandrine Houzé; Bruno Pradine; Renaud Piarroux; Lise Musset; Eric Kendjo
Journal:  JAMIA Open       Date:  2022-03-09

3.  Steroid Pulse Therapy May Mitigate Prolonged Neurological Manifestations after Eradication of Severe Plasmodium falciparum Parasitemia.

Authors:  Chihiro Hasegawa; Akiko Inagaki; Gohei Yamada; Koji Morita; Isamu Kitamura; Koya Ariyoshi
Journal:  Intern Med       Date:  2016-11-15       Impact factor: 1.271

4.  Severe malaria in Europe: an 8-year multi-centre observational study.

Authors:  Florian Kurth; Michel Develoux; Matthieu Mechain; Denis Malvy; Jan Clerinx; Spinello Antinori; Ida E Gjørup; Joaquím Gascon; Kristine Mørch; Emanuele Nicastri; Michael Ramharter; Alessandro Bartoloni; Leo Visser; Thierry Rolling; Philipp Zanger; Guido Calleri; Joaquín Salas-Coronas; Henrik Nielsen; Gudrun Just-Nübling; Andreas Neumayr; Anna Hachfeld; Matthias L Schmid; Pietro Antonini; Tilman Lingscheid; Peter Kern; Annette Kapaun; José Saraiva da Cunha; Peter Pongratz; Antoni Soriano-Arandes; Mirjam Schunk; Norbert Suttorp; Christoph Hatz; Thomas Zoller
Journal:  Malar J       Date:  2017-01-31       Impact factor: 2.979

5.  A Case of Plasmodium falciparum Malaria Treated with Artesunate in a 55-Year-Old Woman on Return to Florida from a Visit to Ghana.

Authors:  Jose A Rodriguez; Alejandra A Roa; Ana-Alicia Leonso-Bravo; Pratik Khatiwada; Paula Eckardt; Juan Lemos-Ramirez
Journal:  Am J Case Rep       Date:  2020-12-20

6.  Artesunate monotherapy versus artesunate plus quinine combination therapy for treatment of imported severe malaria: a TropNet retrospective cohort study.

Authors:  Annarita Botta; Agnese Comelli; Iacopo Vellere; Flavia Chechi; Leila Bianchi; Gardini Giulia; Lina Rachele Tomasoni; Michele Spinicci; Luisa Galli; Francesco Castelli; Alessandro Bartoloni; Lorenzo Zammarchi
Journal:  Infection       Date:  2022-02-27       Impact factor: 7.455

7.  Effect of mild medical hypothermia on in vitro growth of Plasmodium falciparum and the activity of anti-malarial drugs.

Authors:  Khalid Rehman; Ulrich Sauerzopf; Luzia Veletzky; Felix Lötsch; Mirjam Groger; Michael Ramharter
Journal:  Malar J       Date:  2016-03-15       Impact factor: 2.979

8.  Impact of using artemisinin-based combination therapy (ACT) in the treatment of uncomplicated malaria from Plasmodium falciparum in a non-endemic zone.

Authors:  Joaquín Pousibet-Puerto; Joaquín Salas-Coronas; Alicia Sánchez-Crespo; M Angustias Molina-Arrebola; Manuel J Soriano-Pérez; M José Giménez-López; José Vázquez-Villegas; M Teresa Cabezas-Fernández
Journal:  Malar J       Date:  2016-07-02       Impact factor: 2.979

9.  Poor response to artesunate treatment in two patients with severe malaria on the Thai-Myanmar border.

Authors:  Aung Pyae Phyo; Kyaw Kyaw Win; Aung Myint Thu; Lei Lei Swe; Htike Htike; Candy Beau; Kanlaya Sriprawat; Markus Winterberg; Stephane Proux; Mallika Imwong; Elizabeth A Ashley; Francois Nosten
Journal:  Malar J       Date:  2018-01-15       Impact factor: 2.979

10.  Determinants of post-malarial anemia in African children treated with parenteral artesunate.

Authors:  Katrin Scheu; Ayola Akim Adegnika; Marylyn M Addo; Daniel Ansong; Jakob P Cramer; Svenja Fürst; Peter G Kremsner; Florian Kurth; Thomas Jacobs; Jürgen May; Michael Ramharter; Justice Sylverken; Christof D Vinnemeier; Tsiri Agbenyega; Thierry Rolling
Journal:  Sci Rep       Date:  2019-12-02       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.